首页
产品目录
分子砌块
按反应类型
1,2,4-三唑
(4S)-4-((2S)-2-(1-(L-缬氨酰)吡咯烷-2-甲酰胺基)-3-甲基丁酰胺基)-5-(((S)-1-(((S)-1-(((S)-3-羧基-1-((S)-2-(((S)-1-羧基-3-(甲硫基)丙基)氨甲酰基)吡咯烷-1-基)-1-氧代丙烷-2-基)氨基)-3-甲基-1-氧代丁烷-2-基)氨基)-1-氧代丙烷-2-基)氨基)-5-氧代戊酸
(4S)-4-((2S)-2-(1-(L-缬氨酰)吡咯烷-2-甲酰胺基)-3-甲基丁酰胺基)-5-(((S)-1-(((S)-1-(((S)-3-羧基-1-((S)-2-(((S)-1-羧基-3-(甲硫基)丙基)氨甲酰基)吡咯烷-1-基)-1-氧代丙烷-2-基)氨基)-3-甲基-1-氧代丁烷-2-基)氨基)-1-氧代丙烷-2-基)氨基)-5-氧代戊酸
(4S)-4-((2S)-2-(1-(L-valyl)pyrrolidine-2-carboxamido)-3-methylbutanamido)-5-(((S)-1-(((S)-1-(((S)-3-carboxy-1-((S)-2-(((S)-1-carboxy-3-(methylthio)propyl)carbamoyl)pyrrolidin-1-yl)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid
产品编号 :
ACNTBE749
Cas No. :
99291-20-0
包装规格
纯度
目录价
会员专享价
库存
数量
抱歉,暂无牌价信息
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。
基础信息
CAS No.
99291-20-0
中文名称
(4S)-4-((2S)-2-(1-(L-缬氨酰)吡咯烷-2-甲酰胺基)-3-甲基丁酰胺基)-5-(((S)-1-(((S)-1-(((S)-3-羧基-1-((S)-2-(((S)-1-羧基-3-(甲硫基)丙基)氨甲酰基)吡咯烷-1-基)-1-氧代丙烷-2-基)氨基)-3-甲基-1-氧代丁烷-2-基)氨基)-1-氧代丙烷-2-基)氨基)-5-氧代戊酸
英文名称
(4S)-4-((2S)-2-(1-(L-valyl)pyrrolidine-2-carboxamido)-3-methylbutanamido)-5-(((S)-1-(((S)-1-(((S)-3-carboxy-1-((S)-2-(((S)-1-carboxy-3-(methylthio)propyl)carbamoyl)pyrrolidin-1-yl)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid
别名
V-9-M cholecystokinin nonapeptide;Cholecystokinin Precursor (24-32) (rat) H-Val-Pro-Val-Glu-Ala-Val-Asp-Pro-Met-OH;(4S)-4-[[(2S)-2-[[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-3-carboxy-1-[(2S)-2-[[(1S)-1-carboxy-3-methylsulfanylpropyl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid;L-Methionine, L-valyl-L-prolyl-L-valyl-L-α-glutamyl-L-alanyl-L-valyl-L-α-aspartyl-L-prolyl-;L-Valyl-L-prolyl-L-valyl-L-α-glutamyl-L-alanyl-L-valyl-L-α-aspartyl-L-prolyl-L-methionine;Smeglutide;Cholecystokinin Precursor;L-Methionine,L-valyl-L-prolyl-L-valyl-L-a-glutamyl-L-alanyl-L-valyl-L-a-aspartyl-L-prolyl-
标准英文名
(4S)-4-((2S)-2-(1-(L-valyl)pyrrolidine-2-carboxamido)-3-methylbutanamido)-5-(((S)-1-(((S)-1-(((S)-3-carboxy-1-((S)-2-(((S)-1-carboxy-3-(methylthio)propyl)carbamoyl)pyrrolidin-1-yl)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid
分子式
C4 2 H6 9 N9 O1 4 S
分子量
956.13
精确分子量
955.47
SMILES
CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)C1CCCN1C(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)O
标准SMILES
C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)C1CCCN1C(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(O)=O
用途
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for glycemic control in adults with type 2 diabetes mellitus; for reducing the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease; and for chronic weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity.
InChIKey
AIKMAJWJXJPJNB-MHJJKFOESA-N